Abstract | STUDY OBJECTIVES: DESIGN: Prospective, single-site, open-label trial. SETTING: Rehabilitation medicine clinic in Seoul, Korea. PATIENTS: Twenty-nine patients with a confirmed diagnosis of chronic piriformis syndrome and 82 age- and sex-matched healthy subjects were enrolled from April 1, 2003-February 28, 2004. Intervention. In 20 of the patients, botulinum toxin type A 150 U was injected using computed tomographic guidance into the affected unilateral piriformis muscle. The other nine patients served as active controls and received an injection of dexamethasone 5 mg and 1% lidocaine. The healthy subjects did not receive any injection. MEASUREMENTS AND MAIN RESULTS: The patients' pain at baseline and at 4, 8, and 12 weeks after treatment was rated by using a numeric rating scale. Health-related quality of life was assessed by using the validated Korean version of the Medical Outcomes Study 36-Item Short Form Health Survey (SF-36) at baseline and at 4 weeks of treatment. Healthy subjects also completed the SF-36 at baseline. Pain intensity scores were significantly lower at 4, 8, and 12 weeks after treatment than at baseline (p<0.0001). Baseline scores from the SF-36 subscales, including those for physical functioning (p<0.0001), role physical (p<0.0001), bodily pain (p<0.0001), general health (p<0.0001), vitality (p<0.0001), and social functioning (p<0.002), were significantly lower in the patients than in the healthy subjects. Four weeks after treatment, physical functioning (p=0.003), role physical (p=0.021), bodily pain (p=0.016), general health (p=0.013), vitality (p=0.031) and social functioning (p=0.035) improved significantly from baseline in the patients. However, at 4 weeks, patients in the active control group were withdrawn from the study because their pain did not improve, and continuation without further medical care was considered unethical. CONCLUSION:
|
Authors | Se Jin Yoon, Jin Ho, Ho Yeong Kang, Sang Ho Lee, Kyung Im Kim, Wan Gyoon Shin, Jung Mi Oh |
Journal | Pharmacotherapy
(Pharmacotherapy)
Vol. 27
Issue 5
Pg. 657-65
(May 2007)
ISSN: 0277-0008 [Print] United States |
PMID | 17461700
(Publication Type: Clinical Trial, Comparative Study, Journal Article)
|
Chemical References |
- Anesthetics, Local
- Glucocorticoids
- Neuromuscular Agents
- Dexamethasone
- Lidocaine
- Botulinum Toxins, Type A
|
Topics |
- Adult
- Anesthetics, Local
(therapeutic use)
- Asian People
- Botulinum Toxins, Type A
(adverse effects, therapeutic use)
- Dexamethasone
(therapeutic use)
- Female
- Glucocorticoids
(therapeutic use)
- Humans
- Korea
- Lidocaine
(therapeutic use)
- Male
- Middle Aged
- Muscle Contraction
(drug effects)
- Muscle Stretching Exercises
- Muscle, Skeletal
(drug effects)
- Neuromuscular Agents
(adverse effects, therapeutic use)
- Pain
(drug therapy)
- Pain Measurement
- Prospective Studies
- Quality of Life
- Rehabilitation Centers
- Sciatic Nerve
(physiopathology)
- Syndrome
- Tomography, X-Ray Computed
|